Clinical Characteristics and Outcome Analysis for HLA Loss Patients Following Partially Mismatched Related Donor Transplantation Using HLA Chimerism for Loss of Heterozygosity Analysis by Next-Generation Sequencing.

Cell Transplant · 2022 · PMC9178980 · PMID 35670196

Europe PMC DOI

hedged sentence

0.0580

closest p · 1.2× alpha

0.0580

boldest claim

The sentences

a strong trendP = 0.058so close (0.05 < p ≤ 0.1)

Five of 10 HLA mismatches had a strong trend as an independent risk factor (HR: 2.61; 95% CI, 0.97–7.05; P = 0.058).

also in 5,725 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.